Mechanisms of vascular comorbidity in autoimmune diseases

György Nagy, Nóra Németh, E. Búzás

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Purpose of review Persuasive statistics support the clinical observation that because of cardiovascular comorbidities patients with inflammatory joint disease die significantly earlier despite anti-inflammatory therapy. Recent findings The reason for this earlier death is multifactorial and involves a combination of a complex genetic background, environmental influences, classical cardiovascular risk factors and the impact of anti-inflammatory therapy. We will describe the importance of several new mechanisms, especially the diverse intercellular communication routes including extracellular vesicles and microRNAs that support the development of cardiovascular comorbidities. Summary The aim of this review is to give an updated overview about the known risk factors in the development of cardiovascular comorbidities with the latest insights about their mechanism of action. Furthermore, the impact of newly identified risk factors and significance will be discussed.

Original languageEnglish
Pages (from-to)197-206
Number of pages10
JournalCurrent Opinion in Rheumatology
Volume30
Issue number2
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Autoimmune Diseases
Blood Vessels
Comorbidity
Anti-Inflammatory Agents
Joint Diseases
MicroRNAs
Therapeutics
Genetic Background
Extracellular Vesicles

Keywords

  • cardiovascular comorbidities
  • extracellular vesicles
  • microRNA
  • psoriatic arthritis
  • rheumatoid arthritis
  • systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology

Cite this

Mechanisms of vascular comorbidity in autoimmune diseases. / Nagy, György; Németh, Nóra; Búzás, E.

In: Current Opinion in Rheumatology, Vol. 30, No. 2, 01.03.2018, p. 197-206.

Research output: Contribution to journalReview article

Nagy, György ; Németh, Nóra ; Búzás, E. / Mechanisms of vascular comorbidity in autoimmune diseases. In: Current Opinion in Rheumatology. 2018 ; Vol. 30, No. 2. pp. 197-206.
@article{9f14c441b2a449019e153533cda3550a,
title = "Mechanisms of vascular comorbidity in autoimmune diseases",
abstract = "Purpose of review Persuasive statistics support the clinical observation that because of cardiovascular comorbidities patients with inflammatory joint disease die significantly earlier despite anti-inflammatory therapy. Recent findings The reason for this earlier death is multifactorial and involves a combination of a complex genetic background, environmental influences, classical cardiovascular risk factors and the impact of anti-inflammatory therapy. We will describe the importance of several new mechanisms, especially the diverse intercellular communication routes including extracellular vesicles and microRNAs that support the development of cardiovascular comorbidities. Summary The aim of this review is to give an updated overview about the known risk factors in the development of cardiovascular comorbidities with the latest insights about their mechanism of action. Furthermore, the impact of newly identified risk factors and significance will be discussed.",
keywords = "cardiovascular comorbidities, extracellular vesicles, microRNA, psoriatic arthritis, rheumatoid arthritis, systemic lupus erythematosus",
author = "Gy{\"o}rgy Nagy and N{\'o}ra N{\'e}meth and E. B{\'u}z{\'a}s",
year = "2018",
month = "3",
day = "1",
doi = "10.1097/BOR.0000000000000483",
language = "English",
volume = "30",
pages = "197--206",
journal = "Current Opinion in Rheumatology",
issn = "1040-8711",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Mechanisms of vascular comorbidity in autoimmune diseases

AU - Nagy, György

AU - Németh, Nóra

AU - Búzás, E.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Purpose of review Persuasive statistics support the clinical observation that because of cardiovascular comorbidities patients with inflammatory joint disease die significantly earlier despite anti-inflammatory therapy. Recent findings The reason for this earlier death is multifactorial and involves a combination of a complex genetic background, environmental influences, classical cardiovascular risk factors and the impact of anti-inflammatory therapy. We will describe the importance of several new mechanisms, especially the diverse intercellular communication routes including extracellular vesicles and microRNAs that support the development of cardiovascular comorbidities. Summary The aim of this review is to give an updated overview about the known risk factors in the development of cardiovascular comorbidities with the latest insights about their mechanism of action. Furthermore, the impact of newly identified risk factors and significance will be discussed.

AB - Purpose of review Persuasive statistics support the clinical observation that because of cardiovascular comorbidities patients with inflammatory joint disease die significantly earlier despite anti-inflammatory therapy. Recent findings The reason for this earlier death is multifactorial and involves a combination of a complex genetic background, environmental influences, classical cardiovascular risk factors and the impact of anti-inflammatory therapy. We will describe the importance of several new mechanisms, especially the diverse intercellular communication routes including extracellular vesicles and microRNAs that support the development of cardiovascular comorbidities. Summary The aim of this review is to give an updated overview about the known risk factors in the development of cardiovascular comorbidities with the latest insights about their mechanism of action. Furthermore, the impact of newly identified risk factors and significance will be discussed.

KW - cardiovascular comorbidities

KW - extracellular vesicles

KW - microRNA

KW - psoriatic arthritis

KW - rheumatoid arthritis

KW - systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=85042449894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042449894&partnerID=8YFLogxK

U2 - 10.1097/BOR.0000000000000483

DO - 10.1097/BOR.0000000000000483

M3 - Review article

VL - 30

SP - 197

EP - 206

JO - Current Opinion in Rheumatology

JF - Current Opinion in Rheumatology

SN - 1040-8711

IS - 2

ER -